Popular Articles

Bayer Schering Pharma Announces New Data On Novel Anti-cancer Compound BAY 73-4506
Bayer Schering

NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available For Relief Of Moderate To Severe Acute Pain
Patients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets. This new medication for the relief of moderate to severe acute pain in patients 18 years of age or older is now available by prescription only in 50-mg, 75-mg and 100-mg tablets, announced PriCara,(R) Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
News of the day
2009 Dr. Paul Janssen Award For Biomedical Research Won By Axel Ullrich
Johnson & Johnson has announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose discoveries have led to novel cancer therapies including Herceptin® (trastuzumab) , is the winner of the 2009 Dr. Paul Janssen Award for Biomedical Research. An independent committee of world-renowned scientists selected Dr. Ullrich, who on September 8 will receive a $100,000 prize during a ceremony in Beerse, Belgium.
Health Insurance

Wiley-Blackwell Publishes Inaugural Issue Of LUTS (Lower Urinary Tract Symptoms)

Wiley-Blackwell, the scientific, technical, medical and scholarly publishing business of John Wiley & Sons, Inc (NYSE: JWa), (NYSE: JWb), has announced that the inaugural issue of its new journal, LUTS (Lower Urinary Tract Symptoms), is now live online. A new journal providing the latest clinical and basic science information in the field of neurourology, urodynamics, and urogynecology, LUTS is published for the Japanese Neurogenic Bladder Society, Korean Continence Society, and Taiwanese Continence Society. The journal features full color on its website, review articles, original articles, case reports, video articles on surgical techniques, ultrasound diagnosis, and videourodynamics. Editor-in-Chief of LUTS, Professor Osamu Yamaguchi said, "The journal seeks to provide timely communication to physicians and researchers. Helmed by an international editorial board, the journal will address the full spectrum of lower urinary tract dysfunctions." This first issue features an editorial by Professor Yamaguchi; as well as original papers in clinical and basic research, and a number of review articles. Wiley-Blackwell


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):